Haematological Cancer Suspected (Adults & Children)

Size: px
Start display at page:

Download "Haematological Cancer Suspected (Adults & Children)"

Transcription

1 Haematological Cancer Suspected (Adults & Children) Link to NICE guidelines: Patient of any age presents with symptoms of possible haematological cancer If 60 years of age with persistent bone pain, particularly back pain, or unexplained fracture Order FBC, blood tests for calcium and plasma viscosity or ESR Malignant spinal cord compression/acute kidney injury or hypercalcaemia = medical emergency If 60 years of age with hypercalcaemia/ anaemia/ leukopenia/ raised ESR Patient <25 years of age with unexplained petechiae Consider possibility of meningococcal sepsis or severe marrow suppression (leukaemia) Patient <25 years of age with unexplained hepatosplenomegaly Unexplained lymphadenopathy or splenomegaly < 25 years of age 25 years of age Very urgent FBC (WITHIN 48 HRS) Other symptoms consistent with haematological cancer/ leukaemia Also order blood tests for calcium and plasma viscosity or ESR Organise immediate paediatric/ medical assessment Call consultant IMMEDIATELY - URGENT referral within 48 hours Assess for associated symptoms and include in referral (regardless of symptoms) Review FBC within 48hrs Myeloma suspected 2WW suspected haematological cancer Acute Leukaemia not suspected - consider other causes including other cancers If blood testing not consistent with acute Leukaemia consider other causes including other cancers and if 60, myeloma Blood film or FBC suggest Acute Leukaemia If the blood film or FBC suggest Acute Leukaemia NICE recommends immediate referral: call consultant and complete 2WW form Offer protein electrophoresis and a Bence-Jones protein urine test (WITHIN 48 HOURS) Myeloma suspected 60 years of age possible myeloma 25 years of age and cancer not ruled out < 25 years of age and cancer not ruled out Emergency assessment: call paediatric or haematology consultant If results abnormal, 2WW referral for suspected haematological cancer Assess for associated symptoms and include in referral (regardless of symptoms) Call consultant IMMEDIATELY - URGENT referral within 48 hours 2WW suspected haematological cancer

2 If 60 years of age with persistent bone pain, particularly back pain, or unexplained fracture Multiple myeloma can present with a wide variety of symptoms including bone pain. Presenting features include: Bone pain, particularly backache Pathological fractures Spinal cord/nerve root compression Lethargy (due to anaemia) Anorexia. Dehydration (due to proximal tubule dysfunction from light-chain precipitation) Recurrent bacterial infection Bleeding and/or bruising Features suggesting amyloidosis (e.g., cardiac failure, nephrotic syndrome) Signs and symptoms of hypercalcaemia (e.g., thirst, constipation, nausea, confusion. Dizziness, confusion, blurred vision, headaches, epistaxis, cerebrovascular event - due to hyperviscosity If there are signs of spinal cord compression, the patient should be admitted to hospital immediately

3 If 60 years of age with hypercalcaemia/ anaemia/ leukopenia/ raised ESR Multiple myeloma can present with a wide variety of symptoms including hypercalcaemia, anaemia and renal impairment. Presenting features include: Signs and symptoms of hypercalcaemia (e.g., thirst, constipation, nausea, confusion) Lethargy (due to anaemia) Anorexia. Dehydration (due to proximal tubule dysfunction from light-chain precipitation) Recurrent bacterial infection Bleeding and/or bruising Features suggesting amyloidosis (e.g., cardiac failure, nephrotic syndrome) Dizziness, confusion, blurred vision, headaches, epistaxis, cerebrovascular event - due to hyperviscosity Bone pain, particularly backache Pathological fractures Spinal cord/nerve root compression Blood testing may be carried out for other reasons and show: Impaired renal function Anaemia: normochromic, normocytic Leukopenia Thrombocytopenia Hypercalcaemia Persistently raised plasma viscosity or erythrocyte sedimentation rate (ESR) If there are signs of acute kidney injury or hypercalcaemia, the patient should be admitted to hospital immediately. If a paraprotein is found on routine testing, the patient should be referred to an haematologist or oncologist. Multidisciplinary care should follow.

4 Patient <25 years of age with unexplained petechiae Meningitis should be ruled out in children and young people with unexplained petechiae. In addition unexplained petechia may indicate severe marrow suppression and are therefore medical emergencies. Therefore children and young adults < 25 years of age should have immediate specialist assessment.

5 Patient <25 years of age with unexplained hepatosplenomegaly NICE recommends that patients <25 years of age with unexplained petechiae or hepatosplenomegaly are referred urgently within 48 hours. GPs should phone specialist haematological or paediatric consultant to arrange urgent assessment.

6 Unexplained lymphadenopathy or splenomegaly NICE recommends that patients with unexplained lymphadenopathy or splenomegaly are considered for urgent referral for suspected cancer. When considering referral, take into account any associated symptoms, particularly: fever night sweats shortness of breath pruritus or weight loss alcohol-induced lymph node pain

7 Other symptoms consistent with haematological cancer/leukaemia NICE recommendations: Adults Consider a very urgent FBC (within 48 hours) to assess for leukaemia in adults with any of the following: pallor persistent fatigue unexplained fever unexplained persistent or recurrent infection generalised lymphadenopathy unexplained bruising unexplained bleeding unexplained petechiae hepatosplenomegaly NB: If < 25 with unexplained petechiae or hepatosplenomegaly, call consultant IMMEDIATELY for consideration of assessment within 48 hours. Children and young people Offer a very urgent FBC (within 48 hours) to assess for leukaemia in children and young people with any of the following: pallor persistent fatigue unexplained fever unexplained persistent infection generalised lymphadenopathy persistent or unexplained bone pain unexplained bruising unexplained bleeding.

8 60 years of age possible myeloma NB: if patient 60 consider myeloma. Blood results consistent with myeloma include: Anaemia: normochromic, normocytic Leukopenia Thrombocytopenia Hypercalcaemia Persistently raised plasma viscosity or erythrocyte sedimentation rate (ESR) Impaired renal function

9 Offer protein electrophoresis and a Bence-Jones protein urine test (WITHIN 48 HOURS) To assess for myeloma in people aged 60 with hypercalcaemia or leukopenia and a presentation that is consistent with possible myeloma. Consider very urgent protein electrophoresis and a Bence-Jones protein urine test (within 48 hours) to assess for myeloma if the plasma viscosity or erythrocyte sedimentation rate and presentation are consistent with possible myeloma.

Lec-14 د.خالد نافع. Medicine. Multiple Myeloma

Lec-14 د.خالد نافع. Medicine. Multiple Myeloma Fifth stage Lec-14 د.خالد نافع Medicine 24/4/2016 Multiple Myeloma Plasma cell myeloma Variants Non - secretory myeloma Indolent myeloma Smouldering myeloma Plasma cell leukaemia Plasmacytoma - Solitary

More information

Michael Joffe ST6 Haematology SpR

Michael Joffe ST6 Haematology SpR Michael Joffe ST6 Haematology SpR Mrs SB 71 year old female on AMU Telephone referral to haematology by medicine with Hb 102 MCV 89, normal B12, Folate, Ferritin. PMH DM General decline over several weeks

More information

GP Referral Guidelines. for. South Wales Cancer Network. Document Control Sheet. Specialty/Project Haematological Site Specific Group

GP Referral Guidelines. for. South Wales Cancer Network. Document Control Sheet. Specialty/Project Haematological Site Specific Group GP Referral Guidelines for South Wales Cancer Network Document Control Sheet Organisation South Wales Cancer Network Specialty/Project Haematological Site Specific Group Document Title GP Referral Guidelines

More information

Clinical & Laboratory Assessment

Clinical & Laboratory Assessment Clinical & Laboratory Assessment Dr Roger Pool NHLS & University of Pretoria Clinical Assessment (History) Anaemia ( haemoglobin) Dyspnoea (shortness of breath) Tiredness Angina Headache Clinical Assessment

More information

Rory McCulloch. Specialty Trainee Haematology Royal Devon & Exeter Hospital

Rory McCulloch. Specialty Trainee Haematology Royal Devon & Exeter Hospital Rory McCulloch Specialty Trainee Haematology Royal Devon & Exeter Hospital Anaemia 1 Haematological disorders Anaemia 2 Non-haematological disorders Substrates: Iron, folate, vitamin B12 Red cell mass

More information

HEFT Pathology Guideline. GP Investigation and Referral Pathways for leucocyte, platelet disturbances and polycythaemia

HEFT Pathology Guideline. GP Investigation and Referral Pathways for leucocyte, platelet disturbances and polycythaemia HEFT Pathology Guideline GP Investigation and Referral Pathways for leucocyte, platelet disturbances and polycythaemia Produced by: Dr Charalampos Kartsios (Consultant Haematologist) and Muhammad Javed

More information

Southern Derbyshire Shared Care Pathology Guidelines. MGUS (Monoclonal Gammopathy of Undetermined Significance)

Southern Derbyshire Shared Care Pathology Guidelines. MGUS (Monoclonal Gammopathy of Undetermined Significance) Southern Derbyshire Shared Care Pathology Guidelines MGUS (Monoclonal Gammopathy of Undetermined Significance) Purpose of guideline This guideline provides information about the risk stratification of

More information

Management of the complications of myeloma and side-effects of treatment Christine Morris Clinical Nurse Specialist in Myeloma Royal Derby Hospital

Management of the complications of myeloma and side-effects of treatment Christine Morris Clinical Nurse Specialist in Myeloma Royal Derby Hospital Management of the complications of myeloma and side-effects of treatment Christine Morris Clinical Nurse Specialist in Myeloma Royal Derby Hospital Common problems in myeloma Myeloma-related complications/symptoms

More information

Introduction. Please note the toolkit aims to share learning and good practice, but it is, of necessity, brief in nature.

Introduction. Please note the toolkit aims to share learning and good practice, but it is, of necessity, brief in nature. July 2015 edition Introduction The Rapid Referral guidance toolkit has been produced by Macmillan Cancer Support. It contains the NICE referral guidelines for suspected cancer (2015 update) with additional

More information

Anaemias and other Pesky Haematology Questions

Anaemias and other Pesky Haematology Questions Anaemias and other Pesky Haematology Questions 3 main topics How do I work out an anaemia.. That oh too common paraprotein patient. Those mildly raised lymphocyte count GP discussed patient with me over

More information

Haematology for GP's

Haematology for GP's Haematology for GP's Dr Christina Zouvelou Consultant Haematologist SOUTHEND UNIVERSITY HOSPITALS NHS FT SPIRE WELLESLEY HOSPITAL Time to Learn, 03/07/2018 Anaemia Careful history (duration, symptoms,

More information

Early diagnosis saves lives #SpotLeukaemia

Early diagnosis saves lives #SpotLeukaemia Early diagnosis saves lives #SpotLeukaemia Leukaemia... is a blood cancer affects people of all ages Leukaemia symptoms are hard to spot, as they are similar to the symptoms of common, unrelated conditions.

More information

Guideline for the Management of Patients with Myeloma

Guideline for the Management of Patients with Myeloma Version History Guideline for the Management of Patients with Myeloma Version Summary of change Date Issued 1.0 Endorsed by the Governance Committee 11.05.06 1.1 Following review by Guy Pratt 19.02.08

More information

Guidelines for the Management of Chronic Lymphocytic Leukaemia (CLL)

Guidelines for the Management of Chronic Lymphocytic Leukaemia (CLL) Guidelines for the Management of Chronic Lymphocytic Leukaemia (CLL) Version History Version Date Summary of Change/Process 2.0 08.05.08 Endorsed by the Governance Committee 2.1 16.02.11 Circulated at

More information

King s Health Partners Haematology Institute and Network GP Referral Guide, Adult Haematology

King s Health Partners Haematology Institute and Network GP Referral Guide, Adult Haematology King s Health Partners Haematology Institute and Network GP Referral Guide, Adult Haematology For two week wait pathway, please continue to use existing documentation/pathways. Telephone advice and guidance

More information

King s Health Partners Haematology Institute and Network GP Referral Guide, Adult Haematology

King s Health Partners Haematology Institute and Network GP Referral Guide, Adult Haematology King s Health Partners Haematology Institute and Network GP Referral Guide, Adult Haematology 1 Version control: There are two controlled versions of this document, one for GSTT and one for KCH. While

More information

Haematology dilemma s to refer or not to refer?

Haematology dilemma s to refer or not to refer? Haematology dilemma s to refer or not to refer? NWL Pathology GP Study Day Dr Fatts Chowdhury Consultant Haematologist in Transfusion Medicine NHS Blood and Transplant Senior Honorary Clinical Lecturer

More information

Healthcare Improvement Scotland First published May 2014

Healthcare Improvement Scotland First published May 2014 Scottish referral guidelines for suspected cancer: gynaecological; haematological; head and neck; brain and central nervous system; sarcomas and bone; children, teenagers and young adult cancers; and malignant

More information

WHAT ARE PAEDIATRIC CANCERS

WHAT ARE PAEDIATRIC CANCERS WHAT ARE PAEDIATRIC CANCERS INTRODUCTION Childhood cancers are RARE 0.5% of all cancers in the West Overall risk that a child will develop cancer during first 15 years of life is 1 in 450 and 1 in 600

More information

Please list any treatments you have previously had for current illness. (Physical Therapy, Surgery, Radiation, etc.)

Please list any treatments you have previously had for current illness. (Physical Therapy, Surgery, Radiation, etc.) Date: Patient Name: D.O.B Last First M.I History of Present Illness: What is the reason for your visit? Date symptom started? Please list any treatments you have previously had for current illness. (Physical

More information

NICE guideline on Suspected cancer: recognition and referral (2015) Education package for GPs and Nurse Practitioners Case scenarios

NICE guideline on Suspected cancer: recognition and referral (2015) Education package for GPs and Nurse Practitioners Case scenarios NICE guideline on Suspected cancer: recognition and referral (2015) Education package for GPs and Nurse Practitioners Case scenarios How to use the case scenarios The case scenarios can be used in a training

More information

Cancer Care Kenya Notes for General Practioners:

Cancer Care Kenya Notes for General Practioners: Cancer Care Kenya Notes for General Practioners: Site specific symptoms for detecting cancers at an early stage is given below. Please refer patients for detailed work up. 1. Brain /CNS tumors: Sub acute

More information

Cancer: NICE (symptom based)- what s new November 2016

Cancer: NICE (symptom based)- what s new November 2016 Cancer: NICE (symptom based)- what s new November 2016 Dr Katy Gardner, Dr Cathy Hubbert, Macmillan GP Cancer Leads, Liverpool CCG See stalls for more information and local pathways (Cheshire & Merseyside)

More information

Childhood Cancer. Dr Sarah Taaffe. Grace Kelly LadyBird Trust RCGP Child and Young Persons Cancer E-learning Session

Childhood Cancer. Dr Sarah Taaffe. Grace Kelly LadyBird Trust RCGP Child and Young Persons Cancer E-learning Session Childhood Cancer Dr Sarah Taaffe Grace Kelly LadyBird Trust RCGP Child and Young Persons Cancer E-learning Session What I plan to cover in this session Background- Why this topic.. What types of cancer

More information

Palliative Care Emergencies

Palliative Care Emergencies Palliative Care Emergencies LAURA BARNFIELD What might constitute an emergency in Palliative Care? 1 Palliative Care Emergencies Major haemorrhage Metastatic Spinal Cord Compression (MSCC) Superior Vena

More information

By Angela Gascoigne Haematology CNS Chesterfield Royal Hospital

By Angela Gascoigne Haematology CNS Chesterfield Royal Hospital By Angela Gascoigne Haematology CNS Chesterfield Royal Hospital Myeloproliferative Neoplasms Essential Thrombocythaemia Polycythaemia Vera Myelofibrosis Essential Thrombocythaemia (ET) Chronic condition

More information

Plasma cell myeloma (multiple myeloma)

Plasma cell myeloma (multiple myeloma) Plasma cell myeloma (multiple myeloma) Common lymphoid neoplasm, present at old age (70 years average) Remember: plasma cells are terminally differentiated B-lymphocytes that produces antibodies. B-cells

More information

Multiple Myeloma 101: Understanding Your Labs

Multiple Myeloma 101: Understanding Your Labs Multiple Myeloma 101: Understanding Your Labs Tim Wassenaar MD MS Hematologist, Director of Clinical Trials UW Cancer Center at ProHealth Care None Disclosures Outline Define hematopoiesis WBCs, RBCs,

More information

This is a controlled document and therefore must not be changed

This is a controlled document and therefore must not be changed AZACITIDINE NICE TA218 Treatment of adults not eligible for haematopoietic stem cell transplantation who have: Intermediate-2 and high-risk MDS according to the International Prognostic Scoring System

More information

Management of Anaemia

Management of Anaemia Management of Anaemia Janet Birchall Consultant Haematologist North Bristol Trust and NHS Blood & Transplant Case History - DW age 86 years 14.30 FBC by GP Hb 58 g/l, ferritin 3microg/L. Hospital review

More information

Lymphomas and multiple myeloma 12/23/2018 1

Lymphomas and multiple myeloma 12/23/2018 1 60 Lymphomas and multiple myeloma 12/23/2018 1 Lymphomas Lymphoma is cancer of the lymphatic system. Lymphomas are subdivided into two main categories: Hodgkin's lymphoma (HL) and non- Hodgkin's lymphoma

More information

East Kent Summary Guidance suspected cancer referrals and notes GP reference document May 2018

East Kent Summary Guidance suspected cancer referrals and notes GP reference document May 2018 East Kent Summary Guidance suspected cancer referrals and notes GP reference document May 2018 GP INTIATIED DIAGNOSITCS USS Gall Bladder or Liver Fast-track ultrasound to assess for gall bladder or liver

More information

HYDROXYCARBAMIDE for Haematological conditions (Adults)

HYDROXYCARBAMIDE for Haematological conditions (Adults) Shared Care Guideline DRUG: Introduction: Contraindications & Warnings: HYDROXYCARBAMIDE for Haematological conditions (Adults) Indication: Hydroxycarbamide is an established treatment in haematological

More information

Western Health Specialist Clinics Access & Referral Guidelines

Western Health Specialist Clinics Access & Referral Guidelines Haematology Specialist Clinics at Western Health: Western Health runs MBS funded Specialist Clinics on a Wednesday and Thursday afternoon at its Sunshine Hospital site for patients who require assessment

More information

Yorkshire and Humber Children and Young People s Cancer Network Referral, Diagnosis & Staging Protocol

Yorkshire and Humber Children and Young People s Cancer Network Referral, Diagnosis & Staging Protocol Yorkshire and Humber Children and Young People s Cancer Network VALID ON DATE OF PRINTING ONLY - all guidelines available at page 1 of 15 version number: 2.4 i Document Control Title Author(s) Owner Referral,

More information

Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust

Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust Regional Paediatric Specialty Trainees teaching 4 th July 2017 Scope

More information

What is a hematological malignancy? Hematology and Hematologic Malignancies. Etiology of hematological malignancies. Leukemias

What is a hematological malignancy? Hematology and Hematologic Malignancies. Etiology of hematological malignancies. Leukemias Hematology and Hematologic Malignancies Cancer of the formed elements of the blood What is a hematological malignancy? A hematologic malignancy is a malignancy (or cancer) of any of the formed elements

More information

Western Locality Shared care Information ~ Penicillamine, Rheumatology April 2013

Western Locality Shared care Information ~ Penicillamine, Rheumatology April 2013 Western Locality Shared care Information ~ Penicillamine, Rheumatology April 2013 Penicillamine Treatment of: Rheumatoid arthritis Specialist: Please complete the Shared Care letter sending a request to

More information

Burkitt lymphoma. Sporadic Endemic in Africa associated with EBV Translocations involving MYC gene on chromosome 8

Burkitt lymphoma. Sporadic Endemic in Africa associated with EBV Translocations involving MYC gene on chromosome 8 Heme 8 Burkitt lymphoma Sporadic Endemic in Africa associated with EBV Translocations involving MYC gene on chromosome 8 Most common is t(8;14) Believed to be the fastest growing tumor in humans!!!! Morphology

More information

Definition Elevated Adjusted Calcium > 2.6 mmol/l (adjusted for albumin), taken without using a cuff.

Definition Elevated Adjusted Calcium > 2.6 mmol/l (adjusted for albumin), taken without using a cuff. Hypercalcaemia Definition Elevated Adjusted Calcium > 2.6 mmol/l (adjusted for albumin), taken without using a cuff. Mild (usually no symptoms) 2.6 3.0 mmol/l Moderate (start to develop symptoms) 3.0 3.4

More information

Common Haematological Problems in Primary Care

Common Haematological Problems in Primary Care 23 rd March 2019 GP Hot Topics In Primary Care Common Haematological Problems in Primary Care Dr Samar Kulkarni Consultant Haematologist-Oncologist and The Christie Private Care Manchester, UK. Haematology?

More information

M-Protien, what to do next? Ismail A Sharif MD, FRCPc Internal Medicine Day 22 nd April 2016

M-Protien, what to do next? Ismail A Sharif MD, FRCPc Internal Medicine Day 22 nd April 2016 + M-Protien, what to do next? Ismail A Sharif MD, FRCPc Internal Medicine Day 22 nd April 2016 + Disclosures Advisory Boards: AMGEN, Lundbeck, NOVARTIS + Subtypes of Plasma Cell Disorders Increased Plasma

More information

FREEDOM OF INFORMATION ACT 2000 Dudley CCG - Info re Prostate Cancer refferals etc.: RFI0430

FREEDOM OF INFORMATION ACT 2000 Dudley CCG - Info re Prostate Cancer refferals etc.: RFI0430 Freedom of Information Team Dudley CCG Response by email 2nd Floor, Brierley Hill Health and Social Care Centre Venture Way Brierley Hill DY5 1RU 26 May 2016 FREEDOM OF INFMATION ACT 2000 Dudley CCG -

More information

Definition Elevated Adjusted Calcium > 2.6 mmol/l (adjusted for albumin), taken without using a cuff.

Definition Elevated Adjusted Calcium > 2.6 mmol/l (adjusted for albumin), taken without using a cuff. Authoriser: Fiona Davidson Page 1 of 5 Hypercalcaemia Definition Elevated Adjusted Calcium > 2.6 mmol/l (adjusted for albumin), taken without using a cuff. Mild (usually no symptoms) 2.6 3.0 mmol/l Moderate

More information

Management of complications and side-effects of myeloma. Jackie Quinn Myeloma CNS Belfast Trust

Management of complications and side-effects of myeloma. Jackie Quinn Myeloma CNS Belfast Trust Management of complications and side-effects of myeloma Jackie Quinn Myeloma CNS Belfast Trust Common problems in myeloma Myeloma-related complications/symptoms Treatment-related side-effects Myeloma bone

More information

Idiopathic Thrombocytopenic Purpura

Idiopathic Thrombocytopenic Purpura Idiopathic Thrombocytopenic Purpura Title of Guideline Contact Name and Job Title (author) Directorate & Speciality Guideline for the management of idiopathic thrombocytopenic purpura Dr S Stokley, Consultant

More information

Acute Lymphoblastic Leukaemia

Acute Lymphoblastic Leukaemia Acute Lymphoblastic Leukaemia Terri Boyer 17 th October 2006 Overview Disease information: Aetiology of ALL proposed theory, contributing factors Symptoms Complications Diagnostic approaches - morphology

More information

Cancer in Children. Dr Anant Sachdev Cancer Lead Berkshire East, GPSI Palliative Medicine

Cancer in Children. Dr Anant Sachdev Cancer Lead Berkshire East, GPSI Palliative Medicine Cancer in Children Dr Anant Sachdev Cancer Lead Berkshire East, GPSI Palliative Medicine 07976 608871 anant.sachdev@nhs.net Aim of this very short session! Facts and figures relating to Childrens Cancers

More information

SCOTTISH CANCER REFERRAL GUIDELINES REVIEW 2018

SCOTTISH CANCER REFERRAL GUIDELINES REVIEW 2018 SCOTTISH CANCER REFERRAL GUIDELINES REVIEW 2018 Dr Peter Hutchison, Chair of Review Group WHAT & WHY? Scottish Cancer Referral Guidelines 2014 Scottish Primary Care Cancer Group identified need for some

More information

Lung Cancer - Suspected

Lung Cancer - Suspected Lung Cancer - Suspected Shared Decision Making Lung Cancer: http://www.enhertsccg.nhs.uk/ Patient presents with abnormal CXR Lung cancer - clinical presentation History and Examination Incidental finding

More information

Blood Cancers in the Community

Blood Cancers in the Community Over to you, mate Blood Cancers in the Community National Rural Health Conference NZ Rural General Practice Network April 7, 2018 Brian Grainger Haematology Registrar Auckland Acknowledgements Dr James

More information

Guidelines on the Management of a Child with Sickle Cell Disease and low Haemoglobin

Guidelines on the Management of a Child with Sickle Cell Disease and low Haemoglobin Guidelines on the Management of a Child with Sickle Cell Disease and low Haemoglobin Document Information Version: 2 Date: 28 th December 2013 Authors (incl. job title): Professor David Rees (Consultant

More information

TYPE 1 GAUCHER DISEASE PRESENTING AS PERSISTENT THROMBOCYTOPENIA, ASSOCIATED FACTOR XI DEFICIENCY & EMERGENT MYELOMA

TYPE 1 GAUCHER DISEASE PRESENTING AS PERSISTENT THROMBOCYTOPENIA, ASSOCIATED FACTOR XI DEFICIENCY & EMERGENT MYELOMA TYPE 1 GAUCHER DISEASE PRESENTING AS PERSISTENT THROMBOCYTOPENIA, ASSOCIATED FACTOR XI DEFICIENCY & EMERGENT MYELOMA Trish Hyland, Medical Scientist, Department of Haematology, Cork University Hospital

More information

Laboratory diagnosis of plasma proteins and plasma enzymes

Laboratory diagnosis of plasma proteins and plasma enzymes Laboratory diagnosis of plasma proteins and plasma enzymes Functions of plasma proteins Function: transport humoral immunity enzymes protease inhibitors maintenance of oncotic pressure buffering Example:

More information

Alectinib (Alecensa ) Alectinib (Alecensa )

Alectinib (Alecensa ) Alectinib (Alecensa ) Alectinib (Alecensa ) Alectinib (Alecensa ) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary: for some people, treatment may reduce the risk of the cancer

More information

1. What is fulvestrant?

1. What is fulvestrant? Talk to our breast care nurses 0808 800 6000 1. What is fulvestrant? 2. How does fulvestrant work? 3. When might fulvestrant be prescribed? 4. How is fulvestrant given? 5. How long will I be given fulvestrant

More information

Ibrutinib (Imbruvica )

Ibrutinib (Imbruvica ) Ibrutinib (Imbruvica) Ibrutinib (Imbruvica ) This leaflet is offered as a guide to you and your family. Ibrutinib is a type of anti-cancer treatment called a targeted therapy. The aim of this treatment

More information

Clinical Biochemistry Department City Hospital

Clinical Biochemistry Department City Hospital Cancer Biochemistry and Tumour Markers Clinical Biochemistry Department City Hospital In this lecture Cancer basics Definition of Tumour Marker (TM) What is the perfect TM? History of TMs Examples of TMs

More information

Multiple Myeloma Early Detection, Diagnosis, and Staging

Multiple Myeloma Early Detection, Diagnosis, and Staging Multiple Myeloma Early Detection, Diagnosis, and Staging Detection and Diagnosis Catching cancer early often allows for more treatment options. Some early cancers may have signs and symptoms that can be

More information

A Care Pathway exists for the management of neutropenic fever. Copies of the care pathway document are available in EAU, A&E, Deanesly and CHU.

A Care Pathway exists for the management of neutropenic fever. Copies of the care pathway document are available in EAU, A&E, Deanesly and CHU. Subject: Neutropenic Fever Guideline for Junior Doctors Date of Implementation: January 2010 Date of Review: January 2012 Director Responsible for Implementation and Review: Policy location: Consultant

More information

NURSING PROCESS FOCUS: Patients Receiving Amphotericin B (Fungizone, Abelcet)

NURSING PROCESS FOCUS: Patients Receiving Amphotericin B (Fungizone, Abelcet) NURSING PROCESS FOCUS: Patients Receiving Amphotericin B (Fungizone, Abelcet) ASSESSMENT Prior to administration: Obtain complete health history including allergies, drug history, and possible drug interactions.

More information

Greater Manchester Commissioning Hub: Cancer Programme. The ACE Programme. Wave 2 Multidisciplinary Diagnostic Centres

Greater Manchester Commissioning Hub: Cancer Programme. The ACE Programme. Wave 2 Multidisciplinary Diagnostic Centres Greater Manchester Commissioning Hub: Cancer Programme The ACE Programme Wave 2 Multidisciplinary Diagnostic Centres Background / Context GM Pilot focuses on 2 areas of Greater Manchester: Oldham South

More information

Care for patients with Neurological disorders

Care for patients with Neurological disorders King Saud University College of Nursing Medical Surgical Department Application of Adult Health Nursing Skills ( NUR 317 ) Care for patients with Neurological disorders Outline; EEG Overview. Nursing Interventions;

More information

Bowel cancer risk in the under 50s. Greg Rubin Professor of General Practice and Primary Care

Bowel cancer risk in the under 50s. Greg Rubin Professor of General Practice and Primary Care Bowel cancer risk in the under 50s Greg Rubin Professor of General Practice and Primary Care Prevalence of GI problems in the consulting population Thompson et al, Gut 2000 Number of patients % of patients

More information

HYPERCALCEMIA. Babak Tamizi Far MD. Assistant professor of internal medicine Al-zahra hospital, Isfahan university of medical sciences

HYPERCALCEMIA. Babak Tamizi Far MD. Assistant professor of internal medicine Al-zahra hospital, Isfahan university of medical sciences HYPERCALCEMIA Babak Tamizi Far MD. Assistant professor of internal medicine Al-zahra hospital, Isfahan university of medical sciences ESSENTIALS OF DIAGNOSIS Serum calcium level > 10.5 mg/dl Serum ionized

More information

VI.2 Elements for a public summary

VI.2 Elements for a public summary VI.2 Elements for a public summary VI.2.1 Overview of disease epidemiology Leukaemia is a cancer that starts in the blood-forming cells of the bone marrow. Chronic lymphocytic leukaemia (CLL) is a type

More information

Louisa Fleure. Advanced Prostate Cancer Clinical Nurse Specialist. Guys and St Thomas NHS Trust

Louisa Fleure. Advanced Prostate Cancer Clinical Nurse Specialist. Guys and St Thomas NHS Trust Louisa Fleure Advanced Prostate Cancer Clinical Nurse Specialist Guys and St Thomas NHS Trust The classification of advanced prostate cancer The incidence of patients presenting with, or developing advanced

More information

FIT for symptomatic patients. Facilitator name

FIT for symptomatic patients. Facilitator name FIT for symptomatic patients Facilitator name Context colorectal cancer Colorectal cancer in the UK 41,804 new cases in 2015 15,903 deaths in 2014 Fourth most common cancer Second most common cause of

More information

Hydroxyurea (Hydroxycarbamide) - Guidelines for treating children with Sickle Cell Disease

Hydroxyurea (Hydroxycarbamide) - Guidelines for treating children with Sickle Cell Disease Hydroxyurea (Hydroxycarbamide) - Guidelines for treating children with Sickle Cell Disease Patient selection The benefits of hydroxycarbamide should be discussed with all parents/carers of children with

More information

NHS Greater Glasgow & Clyde Managed Clinical Network for Diabetes

NHS Greater Glasgow & Clyde Managed Clinical Network for Diabetes Guidelines for the Diagnosis of Diabetes Mellitus NHS Greater Glasgow & Clyde Managed Clinical Network for Diabetes Lead Authors: Dr Brian Kennon, Dr David Carty June 2015 Review due: December 2016 Diagnosis

More information

New Patient Specialty Intake Form Department of Surgery

New Patient Specialty Intake Form Department of Surgery This form contains questions specific to the Department of Surgery. If you are new to Baylor College of Medicine and have not been seen in any of our offices, please be sure to complete our New Patient

More information

PRIORITIES AND CLINICAL EFFECTIVENESS FORUM

PRIORITIES AND CLINICAL EFFECTIVENESS FORUM PRIORITIES AND CLINICAL EFFECTIVENESS FORUM CANCER - GUIDELINES FOR URGENT REFERRAL OF PATIENTS WITH These guidelines are intended as a quick reference for GPs to ensure appropriate referral of those patients

More information

Referral guidelines for suspected cancer

Referral guidelines for suspected cancer Quick reference guide Issue date: June 2005 Referral guidelines for suspected cancer Clinical Guideline 27 Developed by the National Collaborating Centre for Primary Care Ordering information Copies of

More information

PREOPERATIVE ANAEMIA PATHWAY

PREOPERATIVE ANAEMIA PATHWAY PREOPERATIVE ANAEMIA PATHWAY Surname: Unit No. Forename: DOB: / / Age: NHS Number: Likes to be called: Address: Tel. No. Religion/Spirituality: GP Name: GP Practice: Planned Operation: Postcode: Mobile

More information

Cancer of Unknown Primary (CUP) Protocol

Cancer of Unknown Primary (CUP) Protocol 1 Department of Oncology. Cancer of Unknown Primary (CUP) Protocol Version: Document type: Document sponsor Designation Document author [ s] Designation[s] Approving committee / Group Ratified by: Date

More information

Guidelines on the Management of a Child with Sickle Cell Disease and low Haemoglobin

Guidelines on the Management of a Child with Sickle Cell Disease and low Haemoglobin Guidelines on the Management of a Child with Sickle Cell Disease and low Haemoglobin Version: 6 Date: 2 nd March 2010 Authors: Responsible committee or Director: Review date: Target audience: Stakeholders/

More information

Diagnosis and patient pathway in lymphomas

Diagnosis and patient pathway in lymphomas The Royal Marsden Diagnosis and patient pathway in lymphomas Dr Ian Chau Consultant Medical Oncologist The Royal Marsden Hospital London & Surrey Change Presentation title and date in Footer dd.mm.yyyy

More information

PROBLEMS OF THE HEMATOLOGICAL SYSTEM

PROBLEMS OF THE HEMATOLOGICAL SYSTEM PROBLEMS OF THE HEMATOLOGICAL SYSTEM UNIT 5 Review A & P of Hematological system Outline focused exam Differentiate and start to evaluate diagnostic exams used to assess problems of the hematological system

More information

Vinblastine (Lymphoma)

Vinblastine (Lymphoma) Vinblastine (Lymphoma) Vinblastine (Lymphoma) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the

More information

CASE REPORT Light chain multiple myeloma: an evaluation of its biochemical investigations

CASE REPORT Light chain multiple myeloma: an evaluation of its biochemical investigations Malaysian J Pathol 2017; 39(3) : 311 315 CASE REPORT Light chain multiple myeloma: an evaluation of its biochemical investigations Siti Yazmin ZAHARI SHAM BM, MPath, Subashini C. THAMBIAH MBBS, MPath,

More information

Assessment and diagnosis of chronic fatigue syndrome myalgic encephalomyelitis

Assessment and diagnosis of chronic fatigue syndrome myalgic encephalomyelitis Assessment and diagnosis of chronic fatigue syndrome myalgic A NICE pathway brings together all NICE guidance, quality standards and materials to support implementation on a specific topic area. The pathways

More information

University Journal of Surgery and Surgical Specialties

University Journal of Surgery and Surgical Specialties University Journal of Surgery and Surgical Specialties ISSN 2455-2860 Volume 2 Issue 4 2016 A case of multiple myeloma with cranial nerve palsy SURESHBABU THIRUMAL Department of Neuro Surgery, MADRAS MEDICAL

More information

FBC interpretation. Dr. Gergely Varga

FBC interpretation. Dr. Gergely Varga FBC interpretation Dr. Gergely Varga #1 71 Y/O female, c/o weakness Test Undertaken : FBC (FBC) Sample Type: Whole Blood [ - 26.09.11 14:59] Hb 7.3 g/dl* 12.0-15.5 RBC 3.5 10^12/l * 3.80-5.60 Hct 0.24

More information

GP CME. James Liang Consultant Haematologist. Created by: Date:

GP CME. James Liang Consultant Haematologist. Created by: Date: GP CME James Liang Consultant Haematologist Date: Created by: Scenario 52 year old European male Fit and well Brother recently diagnosed with diabetes PMHx Nil Social Hx Ex-smoker stopped 5 years ago (20

More information

Autoimmune lymphoproliferative syndrome (ALPS)

Autoimmune lymphoproliferative syndrome (ALPS) ALPS Autoimmune lymphoproliferative syndrome (ALPS) Information for families hello@piduk.org 0800 987 8986 www.piduk.org About this leaflet This leaflet is designed to help answer the questions families

More information

Oncologic Care for Old-Aged Patients

Oncologic Care for Old-Aged Patients Oncologic Care for Old-Aged Patients Elderly & Cancer People 65 years or older are at the higher risk for cancer. For all cancers combined, those over 65 years have an incidence rate 10 times greater than

More information

Tretinoin - ATRA (All Trans Retinoic Acid)

Tretinoin - ATRA (All Trans Retinoic Acid) Tretinoin - ATRA (All Trans Retinoic Acid) Indication Treatment of acute promyelocytic leukaemia (APML) Used in combination with chemotherapy. ICD-10 codes C92.4 Regimen details APML induction therapy

More information

Dr Kirsten Herbert. Dr Melita Kenealy. MBBS(Hons) FRCPA FRACP. Common Blood Tests

Dr Kirsten Herbert. Dr Melita Kenealy. MBBS(Hons) FRCPA FRACP. Common Blood Tests Common Blood Tests Your Haematologist may order numerous blood and urine tests to help diagse or manage your condition. Listed below are some of the more common tests that can be ordered in a haematology

More information

THE CLATTERBRIDGE CANCER CENTRE NHS FOUNDATION TRUST. Systemic Anti Cancer Treatment Protocol. EDP + mitotane

THE CLATTERBRIDGE CANCER CENTRE NHS FOUNDATION TRUST. Systemic Anti Cancer Treatment Protocol. EDP + mitotane Systemic Anti Cancer Treatment Protocol EDP + mitotane PROCEDURE REF: MPHAHANEDP (Version No: 1.0) Approved for use in: Symptomatic treatment for advanced (unresectable, metastatic or relapsed) adrenocortical

More information

Suspecting Tumors, or Could it be cancer?

Suspecting Tumors, or Could it be cancer? Suspecting Tumors, or Could it be cancer? Donna E. Reece, M.D. Princess Margaret Cancer Centre University Health Network Toronto, ON CANADA 07 February 2018 Background Low back pain is common However,

More information

Pathology of the Hematopoietic System. Case studies

Pathology of the Hematopoietic System. Case studies Pathology of the Hematopoietic System Case studies Shannon Martinson, September 2015 Signalment: 9 yr-old MC cat Case Study 1 History: Cat had been anorexic and developed bleeding in the eyes Physical

More information

HASPI Medical Biology Lab 03

HASPI Medical Biology Lab 03 Patient 1001 is a 42-year-old female that is experiencing severe heartburn, abdominal pain, bloating, nausea, and vomiting. Ulcers Bleeding sores in the stomach or intestine Gallbladder Disease Gallstones

More information

This information explains the advice about suspected cancer that is set out in NICE guideline NG12.

This information explains the advice about suspected cancer that is set out in NICE guideline NG12. Recognising, investigating and referring people with symptoms of suspected cancer Information for the public Published: 25 June 2015 nice.org.uk About this information NICE guidelines provide advice on

More information

Familial Mediterranean Fever

Familial Mediterranean Fever https://www.printo.it/pediatric-rheumatology/gb/intro Familial Mediterranean Fever Version of 2016 2. DIAGNOSIS AND TREATMENT 2.1 How is it diagnosed? Generally the following approach is followed: Clinical

More information

FBC CASES Vernon Louw Clinical Haematology 2010

FBC CASES Vernon Louw Clinical Haematology 2010 FBC CASES Vernon Louw Clinical Haematology 2010 FOR EACH OF THE FOLLOWING PATIENTS, SELECT THE MOST LIKELY FINDING FROM THE ANALYSIS OF THE PERIPHERAL BLOOD. A patient with infectious mononucleosis. A

More information

Gemcitabine and carboplatin (Breast)

Gemcitabine and carboplatin (Breast) Gemcitabine and carboplatin (Breast) Gemcitabine and carboplatin (Breast) This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy

More information

PATIENT INFORMATION Last Name: First Name: Middle: Date of Birth: EMERGENCY CONTACT INFORMATION PRIMARY INSURANCE INFORMATION

PATIENT INFORMATION Last Name: First Name: Middle: Date of Birth: EMERGENCY CONTACT INFORMATION PRIMARY INSURANCE INFORMATION PATIENT INFORMATION Last Name: First Name: Middle: Date of Birth: Gender: SSN: Race: Marital Status: Address Line: City: State: Zip Code: Home Phone: Work Phone: Email Address: Cell Phone: Primary Care

More information

Leukemias. Prof. Mutti Ullah Khan Head of Department Medical Unit-II Holy Family Hospital Rawalpindi Medical College

Leukemias. Prof. Mutti Ullah Khan Head of Department Medical Unit-II Holy Family Hospital Rawalpindi Medical College Leukemias Prof. Mutti Ullah Khan Head of Department Medical Unit-II Holy Family Hospital Rawalpindi Medical College Introduction Leukaemias are malignant disorders of the haematopoietic stem cell compartment,

More information

Ceritinib (Zykadia )

Ceritinib (Zykadia ) (Ceritinib (Zykadia ) (Xalkori) Ceritinib (Zykadia ) This leaflet is offered as a guide to you and your family. Ceritinib (Zykadia ) is a type of anti-cancer treatment called a targeted therapy. The aim

More information

Hydroxyurea (Hydroxycarbamide) - Guidelines for treating children with Sickle Cell Disease

Hydroxyurea (Hydroxycarbamide) - Guidelines for treating children with Sickle Cell Disease Hydroxyurea (Hydroxycarbamide) - Guidelines for treating children with Sickle Cell Disease Document Information Version: 2 Date: July 2014 Authors (incl. job title): Dr Moira Dick Consultant Paediatrician

More information